PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Powers A. J Thromb Thrombolysis. Jul 2017; 44(1): 88-93 Pubmed [7343]
Pöyhiä et al. Curr Ther Res (1992) 51, 739-449 [560]
Poyurovsky M. Am J Psychiatry. May 2001; 158(5): 819 Pubmed [12946]
Poyurovsky M. Biol Psychiatry. Jun 2006; 59(11): 1071-7 Pubmed [9878]
Pozniak AL. Br J Clin Pharmacol. Apr 2008; 65 Suppl 1: 54-9 Pubmed, Volltext, DOI [6870]
Pozzi G. Drug Alcohol Depend. Jun 2000; 59(3): 287-94 Pubmed [3357]
Prabhakar M. Heart Rhythm. Nov 2004; 1(5): 624-6 Pubmed [5730]
Pradeep Rao, Nishant Bhagat, Bharat Shah, Momin Bazegha. Indian J Psychiatry.. Jan 2005; 47(1): 65-66 Pubmed [9781]
Praharaj et al. Am J Ther. 2010 Jan 8. [E-pub ahead] [509]
Praharaj SK. Br J Clin Pharmacol. Jan 2007; 63(1): 128-9 Pubmed, Volltext, DOI [8035]
Praharaj und Arora (2006) Br J Clin Pharmacol 63:128-129 [2616]
Prakash C, Kamel A, Cui D, Whalen RD, Miceli JJ, Tweedie DJ. Ziprasidone metabolism and cytochrome P450 isoforms. Biol Psychiatry (1997) 42, 42S [2494]
Prakash C. Br J Clin Pharmacol. Jan 2000; 49 Suppl 1: 35S-42S Pubmed, Volltext, DOI [233]
Prakash R. Indian J Med Sci. Feb 2009; 63(2): 77-80 Pubmed [580]
Prakash S. Seizure. Oct 2021; 91: 117-131 Pubmed [11204]
Prami T. Eur J Clin Pharmacol. Feb 2020; 76(2): 257-265 Pubmed [9356]
Prange et al. JAMA (1972) 219, 143-144 [1585]
Prasad B. Sleep. Jul 2010; 33(7): 982-9 Pubmed, Volltext [3164]
Prasad F. Ther Adv Psychopharmacol. Apr 2023; 13: 20451253231165169 Pubmed [13568]
Prasertpetmanee S. Helicobacter. Aug 2013; 18(4): 270-3 Pubmed [7669]
Pratt C. Clin Exp Allergy. Jul 1999; 29 Suppl 3: 212-6 Pubmed [8346]
Pratt-Hyatt M. Drug Metab Dispos. Dec 2010; 38(12): 2286-92 Pubmed, Volltext, DOI [4816]
Premoli M. Life Sci. May 2019; 224: 120-127 Pubmed [12279]
Prendiville S. Epilepsia. Mar 1993; 34(2): 381-4 Pubmed [10692]
Prescott LF. Am J Ther. Mar 2000; 7(2): 143-7 Pubmed [8464]
Prescott LF. Br J Clin Pharmacol. Apr 2000; 49(4): 291-301 Pubmed, Volltext, DOI [3500]
Prescribing Information for Seroquel, USA, 06/05) [2758]
Prescrire Int. 2001 Oct;10(55):151. Pubmed [6019]
Prescrire Int. Apr 2004; 13(70): 57 Pubmed [3949]
Prescrire Int. Apr 2012; 21(126): 93-6 Pubmed [3460]
Prescrire Int. Feb 2010; 19(105): 12-4 Pubmed [3771]
Prescrire Int. Sep 2011; 20(119): 216-9 Pubmed [3348]
Presecki P. Psychiatr Danub. Jun 2010; 22(2): 360-2 Pubmed [3145]
Preskorn S. J Clin Psychopharmacol. Feb 2009; 29(1): 39-43 Pubmed [12606]
Preskorn SH. J Clin Psychopharmacol. Apr 1994; 14(2): 90-8 Pubmed [1223]
Preskorn SH. J Clin Psychopharmacol. Feb 2007; 27(1): 28-34 Pubmed [2542]
Preskorn SH. J Psychiatr Pract. Jan 2007; 13(1): 5-12 Pubmed [957]
Preskorn SH. J Psychiatr Pract. Jan 2023; 29(1): 38-41 Pubmed [12747]
Preskorn SH. J Psychiatr Pract. Nov 2008; 14(6): 368-78 Pubmed [4483]
Preskorn SH. JAMA. Jun 1997; 277(21): 1682 Pubmed [542]
Preskorn, Flockart. Primary Psychiatry 2009;16:45-74 [3057]
Preskorn, Flockart. Primary Psychiatry 2009;16(12):45-74 [3094]
Preston CL (2014). Stockley's Drug Interactions Pocket companion 2015 (pp 530). London, England: Pharmaceutical Press [4106]
Preston CL (2014). Stockley's Drug Interactions Pocket companion 2015. London, England: Pharmaceutical Press [4304]
Preston CL, (2014). Stockley's Drug Interactions pocket companion 2015. London, England: Pharmaceutical Press [4108]
Preston GC. Anaesthesia. Sep 1996; 51(9): 827-30 Pubmed [2328]
Preston KL. Clin Pharmacol Ther. Oct 1984; 36(4): 534-41 Pubmed [1266]
Preveden N. Eur J Case Rep Intern Med. May 2022; 9(5): 003349 Pubmed [12675]
Previsdomini M. Br J Clin Pharmacol. May 2019 Pubmed [7613]
Previtera AM. J Med Case Rep. Aug 2010; 4: 269 Pubmed, Volltext, DOI [8143]
Prezelj A. Curr Med Chem. Feb 2003; 10(4): 281-90 Pubmed [13875]
Price LH. Am J Psychiatry. May 1985; 142(5): 619-23 Pubmed [11542]
Price LH. J Clin Psychopharmacol. Oct 1990; 10(5): 312-7 Pubmed [8310]
Prichard et al. Br J Clin Pharmacol 1987; 24: 543–545 [2159]
Prichard MN. Antimicrob Agents Chemother. Jun 1991; 35(6): 1060-5 Pubmed, Volltext [7278]
Priest et al. Clin Pharmacokinet (1995) 29, 142-53 [2506]
Prieto-Pérez R. J Clin Pharmacol. Dec 2013; 53(12): 1261-7 Pubmed [8440]
Prime K. Sex Transm Infect. Aug 2001; 77(4): 297-8 Pubmed, Volltext, DOI [6041]
Prince RA. J Allergy Clin Immunol. Dec 1981; 68(6): 427-31 Pubmed [5980]
Pringsheim T. Can J Neurol Sci. Mar 2012; 39(2 Suppl 2): S1-59 Pubmed [2476]
Pringsheim T. Can J Psychiatry. Nov 2018; 63(11): 719-729 Pubmed [12947]
Prior FH. Med J Aust. Mar 2002; 176(5): 240-1 Pubmed [12514]
Priori SG. N Engl J Med. May 2003; 348(19): 1866-74 Pubmed [9074]
Prisant LM. J Clin Pharmacol. Feb 2008; 48(2): 225-39 Pubmed [4209]
Priskorn M. Br J Clin Pharmacol. Aug 1997; 44(2): 199-202 Pubmed, Volltext, DOI [1009]
Priskorn M. Eur J Clin Pharmacol. Jan 1997; 52(3): 241-2 Pubmed [975]
Prober CG. N Engl J Med. Mar 1985; 312(12): 788-9 Pubmed [6120]
Procainamide. Drugbank Online. Stand Jun 2021. https://go.drugbank.com/drugs/DB01035 [10590]
Proctor EA. Br Med J. Dec 1971; 4(5788): 661-2 Pubmed, Volltext [5278]
Prodromos CC. New Microbes New Infect. Sep 2020; 37: 100747 Pubmed, Volltext, DOI [10562]
Product insert "Myleran IV®" [2101]
Product insert Myleran IV® [3490]
Prof. Dr. med. Lothar Färber und Dr. med. Andreas Kreiß. Fingolimod (Gilenya®): Kontraindikationen bei Patienten mit kardialen Erkrankungen. Novartis Pharma GmbH. Stand Nov 2017. https://www.akdae.de/Arzneimittelsicherheit/RHB/Archiv/2017/20171106.pdf [10026]
Prof. Dr. med. Lothar Färber und Dr. med. Andreas Kreiß. Strengere kardiovaskuläre Überwachung zu Beginn der Therapie mit Gilenya (Fingolimod) bei Patienten mit schubförmig-remittierend verlaufender Multipler Sklerose (Rote Hand Brief). Novartis Pharma GmbH. Stand Jan 2012. https://www.akdae.de/Arzneimittelsicherheit/RHB/Archiv/2012/20120125.pdf [10019]
Prof.Dr. Dieter Schmidt. Zeitschrift für Epileptologie. 2008(4) Pubmed [9202]
Projean D. Drug Metab Dispos. Jun 2003; 31(6): 748-54 Pubmed [86]
Promphan W. Pacing Clin Electrophysiol. Jun 2003; 26(6): 1424-6 Pubmed [10451]
Prosser JM. Int J Emerg Med. Sep 2008; 1(3): 217-20 Pubmed, Volltext, Springer [5050]
Protti M. Med Res Rev. Sep 2020; 40(5): 1794-1832 Pubmed [9594]
Provigil (Modafinil), Cephalon (US). Product literature, January 1999 [758]
Prueksaritanont T. Br J Clin Pharmacol. Jul 2003; 56(1): 120-4 Pubmed, Volltext, DOI [206]
Prueksaritanont T. Drug Metab Dispos. May 2002; 30(5): 505-12 Pubmed [345]
Prueksaritanont T. Drug Metab Dispos. Oct 1997; 25(10): 1191-9 Pubmed [3279]
Prueksaritanont T. J Pharmacol Exp Ther. Jun 2002; 301(3): 1042-51 Pubmed [4753]
Prueksaritanont T. Pharm Res. Jan 2005; 22(1): 71-8 Pubmed [4360]
Przewłocki R. Eur J Pharmacol. Oct 2001; 429(1-3): 79-91 Pubmed [8592]
Psevdos G Jr. AIDS Read. Jun 2009; 19(6): 245-8 Pubmed [5700]
Psychopharmakotherapie (PPT), Sept./Okt. 2005;12:195-197 [2591]
Public statement on Crixivan : Withdrawal of the marketing authorisation in the European Union. EMA. Stand Jan 2025. https://www.ema.europa.eu/en/documents/public-statement/public-statement-crixivan-withdrawal-marketing-authorisation-european-union_en.pdf [13891]
Puech R. Br J Clin Pharmacol. Apr 2011; 71(4): 621-3 Pubmed, Volltext, DOI [3240]
Puglia LT. Front Endocrinol (Lausanne). Nov 2023; 14: 1269781 Pubmed [13639]
Puglisi GM. J Clin Pharm Ther. Feb 2017; 42(1): 115-118 Pubmed [6943]
Pukrittayakamee S. Antimicrob Agents Chemother. Jun 2014; 58(6): 3354-9 Pubmed, Volltext, DOI [5130]
Pukrittayakamee S. Antimicrob Agents Chemother. Mar 1994; 38(3): 511-4 Pubmed, Volltext, DOI [8494]
Pukrittayakamee S. Antimicrob Agents Chemother. May 2003; 47(5): 1509-13 Pubmed, Volltext, DOI [6160]
Pullar T. Br J Clin Pharmacol. Mar 1987; 23(3): 317-21 Pubmed, Volltext [1011]
Punwani NG. Clin Pharmacol Ther. Apr 2004; 75(4): 363-5 Pubmed [11607]
Puoti M. Dig Liver Dis. Sep 2013; 45 Suppl 5: S355-62 Pubmed [7208]
Puozzo C. Clin Pharmacokinet. Jan 2005; 44(9): 977-88 Pubmed [4246]